Koya Medical launches Dayspring lower extremity active compression treatments for lymphoedema and venous disorders


Koya Medical recently announced the US commercial availability of its Dayspring active compression system for the treatment of lymphoedema and venous diseases in lower extremities. The company also announced that the Centers for Medicare & Medicaid Services (CMS) issued three new billing codes in accordance with the Healthcare Common Procedure Coding System (HCPCS) for the Dayspring active compression system. The new codes became effective for provider billing on 1 April 2022.

The company claims that Dayspring is the first non-pneumatic active dynamic compression treatment cleared by the US Food and Drug Administration (FDA). Dayspring supports essential body movement and mobility so patients can continue their daily activities during treatment, unlike current pneumatic (air-based) compression pumps that require patients to be stationary and the devices to be plugged into an outlet, a press release details.

The Dayspring treatment for the upper extremity has been commercially available since 2021, and the expansion into lower extremity care—available in both full and lower leg applications—allows the company to better support people living with lymphoedema and venous diseases.

“Daily essential movement helps promote healthy lymph fluid flow, which is important for managing lymphoedema, venous insufficiency, and other chronic oedemas. We designed Dayspring active compression to help patients remain mobile, get the treatment they need instead of letting it get in the way,” said Andy Doraiswamy, Koya Medical founder and CEO. “We look forward to providing at-home active compression treatment options that allow natural leg movements to help reduce swelling and maintain limb volume for people living with lymphedema and venous insufficiency in their lower extremities.”

“Securing codes from CMS is a significant step for advancing new treatment options for patients living with lymphedema and their caregivers and providers,” said Kelly Petrucci, vice president of Strategic Market Access and Health Economics at Koya Medical. “We appreciate the recognition of the new codes, and this significant milestone is critically important to help ensure patients have access to treatments like Dayspring.”

Koya Medical communicates that the Dayspring system includes a soft, breathable mesh garment made with the company’s proprietary Flexframe technology, which are highly durable spring-like segments designed to deliver controlled and customisable compression while allowing natural movement. The company adds that the system also comes with a smart, rechargeable and Bluetooth-enabled controller and a companion app that allows users and their clinicians to customise treatments and review treatment history.



Please enter your comment!
Please enter your name here